Purpose of Review <p>To summarize the recent literature examining the degree of overlap among atrial fibrillation (AF), heart failure (HF), and left atrial (LA) dysfunction, the prognostic relevance of finding a second condition in one of the other disease states, and the treatment effects for one condition on the secondary entities.</p> Recent Findings <p>If one condition (AF, HF, or LA dysfunction) is present, there are very high prevalences of a second condition demonstrated across several cohorts. Additionally, the presence of a second condition consistently has a negative impact on prognosis. Treatment effects for AF or HF tend to show bidirectional benefit, whereas data is limited toward impacts on LA dysfunction.</p> Summary <p>Patients with AF, HF, or LA dysfunction often have more than one of these conditions (either clinically manifest or occult), which may influence prognosis. Established treatment pathways for AF or HF tend to show benefits in the second condition, whereas there is limited data to determine effects on LA dysfunction, or whether LA dysfunction may be directly targeted for therapy.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Left Atrial Dysfunction in Patients with Atrial Fibrillation and Heart Failure

  • Cory R. Trankle,
  • Ajay Pillai,
  • Hussein Krayem,
  • Keyur B. Shah,
  • Kenneth A. Ellenbogen,
  • W. Gregory Hundley

摘要

Purpose of Review

To summarize the recent literature examining the degree of overlap among atrial fibrillation (AF), heart failure (HF), and left atrial (LA) dysfunction, the prognostic relevance of finding a second condition in one of the other disease states, and the treatment effects for one condition on the secondary entities.

Recent Findings

If one condition (AF, HF, or LA dysfunction) is present, there are very high prevalences of a second condition demonstrated across several cohorts. Additionally, the presence of a second condition consistently has a negative impact on prognosis. Treatment effects for AF or HF tend to show bidirectional benefit, whereas data is limited toward impacts on LA dysfunction.

Summary

Patients with AF, HF, or LA dysfunction often have more than one of these conditions (either clinically manifest or occult), which may influence prognosis. Established treatment pathways for AF or HF tend to show benefits in the second condition, whereas there is limited data to determine effects on LA dysfunction, or whether LA dysfunction may be directly targeted for therapy.